Notification

No new Notification messages

Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.
NSE BSE
nifty pharma

Nifty Pharma

23043.4 -113.29 (-0.48%)
Sep 06 2024 03:30 PM Sector: -

26084

Nifty Pharma

img img img img
No Data Available

Nifty Pharma Performance

Day Range

Low22988.90 High23233.15
23031.20

52 Week Range

Low 14544.25 High 23404.85
23031.20

Open Price

23154.70

Prev. Close

23156.70

Volume (Shares)

.00

Total traded value

.00

Upper Circuit

.00

Lower Circuit

.00

    

An Overview

The pharmaceutical sector is one of the most important and dynamic sectors in the Indian economy. It contributes to the health and well-being of millions of people, both in India and abroad. It also provides employment opportunities, exports, and innovation. In this blog post, we will take a look at the Nifty Pharma Index, which captures the performance of the pharmaceutical sector in India.

 

What is the Nifty Pharma Index?

The Nifty Pharma Index is an index that tracks the performance of 20 companies listed on the National Stock Exchange of India (NSE) that are engaged in the pharmaceutical business. The index was launched on January 1, 2001, with a base value of 1000.

 

The free float market value is the product of the total number of shares and the price of each share. The free float market value excludes the shares held by the promoters, government, strategic investors, and other locked-in shares that will not be traded in the normal course. The index is rebalanced semi-annually, in January and July, to ensure that it reflects the current market conditions and composition of the sector.

 

Why is the Nifty Pharma Index important?

The Nifty Pharma Index is important because it provides a benchmark for the performance of the pharmaceutical sector in India. It can be used for a variety of purposes, such as:

 

  • Launching of index funds, ETFs, and structured products: Index funds, exchange-traded funds (ETFs), and structured products are financial instruments that replicate the performance of an underlying index. By launching such products based on the Nifty Pharma Index, investors can gain exposure to the pharmaceutical sector in India without having to buy individual stocks. This can reduce the transaction costs, diversify the risk, and provide liquidity.

  • Research and analysis: Researchers and analysts can use the index to study the trends, patterns, and drivers of the pharmaceutical sector in India. They can also use the index to identify the opportunities and challenges faced by the sector and its constituents.

 

What are the factors that affect the Nifty Pharma Index?

The Nifty Pharma Index is affected by various factors, both internal and external, that influence the performance of the pharmaceutical sector in India. Some of the key factors are:

 

  • Regulatory environment: The pharmaceutical sector in India is regulated by various authorities, such as the Central Drugs Standard Control Organization (CDSCO), the Drug Controller General of India (DCGI), the National Pharmaceutical Pricing Authority (NPPA), the Department of Pharmaceuticals (DoP), and the Ministry of Health and Family Welfare (MoHFW). These authorities set the standards, guidelines, and policies for the approval, manufacturing, pricing, marketing, and distribution of drugs in India. Any changes in the regulatory environment can have a significant impact on the operations, profitability, and competitiveness of the pharmaceutical companies in India.

  • Research and development: The pharmaceutical sector in India is driven by research and development (R&D) activities that aim to discover, develop, and launch new and innovative drugs in the market. R&D activities require substantial investments, time, and resources, and involve a high degree of uncertainty and risk. The success or failure of R&D activities can affect the growth, reputation, and market share of the pharmaceutical companies in India.

  • Competition: The pharmaceutical sector in India faces intense competition from both domestic and international players. The domestic players compete on the basis of price, quality, product portfolio, distribution network, and customer loyalty. The international players compete on the basis of technology, innovation, branding, and patents. The competition can affect the pricing, margins, and market share of the pharmaceutical companies in India.

  • Demand and supply: The demand and supply of drugs in India are influenced by various factors, such as the population, income, health awareness, disease prevalence, government policies, insurance coverage, and consumer preferences. The demand and supply of drugs can also be affected by external factors, such as the global pandemic, natural disasters, geopolitical tensions, and trade barriers. The demand and supply of drugs can affect the revenue, profitability, and inventory of the pharmaceutical companies in India.

 

Wrapping Up

The Nifty Pharma Index is a comprehensive and representative index that reflects the performance of the pharmaceutical sector in India. The index provides a useful tool for investors, fund managers, researchers, and analysts to gain insights into the sector and its constituents. The index is also a reflection of the opportunities and challenges faced by the sector in the dynamic and competitive environment. The index is expected to continue to evolve and adapt to the changing needs and expectations of the stakeholders in the sector.

 

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory. 

 

Click Here For Research Disclaimers: https://bit.ly/3Tcsfuc

All Indices

  • NSE
  • BSE
NAME PRICE CHANGE CHANGE % PREVIOUS CLOSE
Nifty 50
24852.15
arrowup arrowndown
-292.95 -1.17% 25145.10 forward-arrow
India VIX
15.22
arrowup arrowndown
1.01 7.11% 14.21 forward-arrow
Nifty Bank
50576.85
arrowup arrowndown
-896.20 -1.74% 51473.05 forward-arrow
Nifty 100
25928.55
arrowup arrowndown
-310.55 -1.18% 26239.10 forward-arrow
Nifty 200
14107.40
arrowup arrowndown
-178.60 -1.25% 14286.00 forward-arrow
Nifty Fin Service
23529.75
arrowup arrowndown
-329.75 -1.38% 23859.50 forward-arrow
Nifty 500
23477.70
arrowup arrowndown
-285.10 -1.20% 23762.80 forward-arrow
NIFTY Alpha 50
58824.25
arrowup arrowndown
-896.80 -1.50% 59721.05 forward-arrow
Nifty Auto
25527.15
arrowup arrowndown
-308.15 -1.19% 25835.30 forward-arrow
Nifty CPSE
7007.70
arrowup arrowndown
-120.70 -1.69% 7128.40 forward-arrow
Nifty Energy
42212.45
arrowup arrowndown
-699.15 -1.63% 42911.60 forward-arrow
Nifty GS 4 8Yr
2917.58
arrowup arrowndown
0.92 0.03% 2916.66 forward-arrow
Nifty GS 8 13Yr
2697.39
arrowup arrowndown
2.01 0.07% 2695.38 forward-arrow
NIFTY INDIA MFG
14906.00
arrowup arrowndown
-168.15 -1.12% 15074.15 forward-arrow
Nifty Infra
9183.90
arrowup arrowndown
-134.85 -1.45% 9318.75 forward-arrow
Nifty IT
42228.90
arrowup arrowndown
-415.75 -0.97% 42644.65 forward-arrow
Nifty Media
2059.90
arrowup arrowndown
-22.95 -1.10% 2082.85 forward-arrow
Nifty Metal
9161.15
arrowup arrowndown
-51.80 -0.56% 9212.95 forward-arrow
Nifty Midcap 50
16413.95
arrowup arrowndown
-291.20 -1.74% 16705.15 forward-arrow
Nifty MNC
30708.30
arrowup arrowndown
-296.40 -0.96% 31004.70 forward-arrow
Nifty Next 50
74462.00
arrowup arrowndown
-1023.95 -1.36% 75485.95 forward-arrow
Nifty Pharma
23043.40
arrowup arrowndown
-113.30 -0.49% 23156.70 forward-arrow
Nifty PSE
11055.20
arrowup arrowndown
-226.35 -2.01% 11281.55 forward-arrow
Nifty PSU Bank
6655.05
arrowup arrowndown
-246.15 -3.57% 6901.20 forward-arrow
Nifty Pvt Bank
25328.80
arrowup arrowndown
-396.70 -1.54% 25725.50 forward-arrow
Nifty Realty
1032.10
arrowup arrowndown
-9.85 -0.95% 1041.95 forward-arrow
NIFTY SMLCAP 50
9226.60
arrowup arrowndown
-95.90 -1.03% 9322.50 forward-arrow
NIFTY TOTAL MKT
13230.00
arrowup arrowndown
-160.50 -1.20% 13390.50 forward-arrow
Nifty100 Liq 15
6785.70
arrowup arrowndown
-98.35 -1.43% 6884.05 forward-arrow
Nifty GS 10Yr
2387.98
arrowup arrowndown
1.76 0.07% 2386.22 forward-arrow
Nifty FMCG
63175.70
arrowup arrowndown
-524.70 -0.82% 63700.40 forward-arrow
Nifty Commodities
9291.95
arrowup arrowndown
-121.85 -1.29% 9413.80 forward-arrow
NIFTY CONSR DURBL
41531.10
arrowup arrowndown
-342.70 -0.82% 41873.80 forward-arrow
Nifty Consumption
12064.50
arrowup arrowndown
-62.75 -0.52% 12127.25 forward-arrow
Nifty Div Opps 50
6763.70
arrowup arrowndown
-112.30 -1.63% 6876.00 forward-arrow
Nifty FinSrv25 50
26438.25
arrowup arrowndown
-361.10 -1.35% 26799.35 forward-arrow
Nifty GrowSect 15
12611.30
arrowup arrowndown
-125.45 -0.98% 12736.75 forward-arrow
Nifty GS 10Yr Cln
887.64
arrowup arrowndown
0.50 0.06% 887.14 forward-arrow
Nifty GS 11 15Yr
2990.60
arrowup arrowndown
1.85 0.06% 2988.75 forward-arrow
Nifty GS 15YrPlus
3317.41
arrowup arrowndown
1.39 0.04% 3316.02 forward-arrow
Nifty GS Compsite
2795.15
arrowup arrowndown
1.94 0.07% 2793.21 forward-arrow
NIFTY HEALTHCARE
14449.80
arrowup arrowndown
-49.15 -0.34% 14498.95 forward-arrow
NIFTY IND DIGITAL
9415.80
arrowup arrowndown
-107.05 -1.12% 9522.85 forward-arrow
NIFTY LARGEMID250
16365.60
arrowup arrowndown
-211.65 -1.28% 16577.25 forward-arrow
NIFTY M150 QLTY50
25444.70
arrowup arrowndown
-209.30 -0.82% 25654.00 forward-arrow
NIFTY MICROCAP250
24957.35
arrowup arrowndown
-297.00 -1.18% 25254.35 forward-arrow
Nifty Mid Liq 15
14003.15
arrowup arrowndown
-188.65 -1.33% 14191.80 forward-arrow
NIFTY MID SELECT
13066.05
arrowup arrowndown
-211.35 -1.59% 13277.40 forward-arrow
NIFTY MIDCAP 100
58501.95
arrowup arrowndown
-946.55 -1.59% 59448.50 forward-arrow
NIFTY MIDCAP 150
21675.80
arrowup arrowndown
-301.10 -1.37% 21976.90 forward-arrow
NIFTY MIDSML 400
20524.55
arrowup arrowndown
-258.10 -1.24% 20782.65 forward-arrow
NIFTY OIL AND GAS
13024.55
arrowup arrowndown
-287.75 -2.16% 13312.30 forward-arrow
Nifty Serv Sector
31718.70
arrowup arrowndown
-369.60 -1.15% 32088.30 forward-arrow
NIFTY SMLCAP 100
19276.05
arrowup arrowndown
-244.90 -1.25% 19520.95 forward-arrow
NIFTY SMLCAP 250
18307.85
arrowup arrowndown
-187.50 -1.01% 18495.35 forward-arrow
NIFTY100 EQL Wgt
34228.10
arrowup arrowndown
-374.90 -1.08% 34603.00 forward-arrow
NIFTY100 LowVol30
20651.15
arrowup arrowndown
-125.95 -0.61% 20777.10 forward-arrow
NIFTY100 Qualty30
6072.00
arrowup arrowndown
-40.60 -0.66% 6112.60 forward-arrow
Nifty100ESGSecLdr
4159.25
arrowup arrowndown
-43.45 -1.03% 4202.70 forward-arrow
NAME PRICE CHANGE CHANGE % PREVIOUS CLOSE
SENSEX
81183.93
-1017.23 -1.24% 82201.16 forward-arrow
BSE100
26376.75
-315.02 -1.18% 26691.77 forward-arrow
SNSX50
26130.45
-316.29 -1.20% 26446.74 forward-arrow
BSE200
11525.68
-142.94 -1.22% 11668.62 forward-arrow
BSE500
37054.24
-442.56 -1.18% 37496.80 forward-arrow
BSE CG
71143.40
-1232.11 -1.70% 72375.51 forward-arrow
BSE CD
63873.68
-522.33 -0.81% 64396.01 forward-arrow
BSEPSU
21123.55
-538.09 -2.48% 21661.64 forward-arrow
TECK
19538.82
-241.09 -1.22% 19779.91 forward-arrow
BANKEX
57292.63
-1127.43 -1.93% 58420.06 forward-arrow
AUTO
57659.01
-757.88 -1.30% 58416.89 forward-arrow
METAL
31323.32
-200.85 -0.64% 31524.17 forward-arrow
OILGAS
31705.80
-709.93 -2.19% 32415.73 forward-arrow
DOL30
7941.14
-94.70 -1.18% 8035.84 forward-arrow
DOL100
3251.03
-36.85 -1.12% 3287.88 forward-arrow
DOL200
2286.25
-26.95 -1.17% 2313.20 forward-arrow
REALTY
8066.91
-70.26 -0.86% 8137.17 forward-arrow
POWER
7987.03
-111.14 -1.37% 8098.17 forward-arrow
BSEIPO
16511.16
-79.82 -0.48% 16590.98 forward-arrow
GREENX
7827.50
33.63 0.43% 7793.87 forward-arrow
CARBON
4344.48
15.78 0.36% 4328.70 forward-arrow
SMEIPO
103419.02
-2249.27 -2.13% 105668.29 forward-arrow
INFRA
703.15
-12.68 -1.77% 715.83 forward-arrow
CPSE
4260.31
-84.57 -1.95% 4344.88 forward-arrow
MIDCAP
48504.84
-692.03 -1.41% 49196.87 forward-arrow
SMLCAP
55977.86
-543.75 -0.96% 56521.61 forward-arrow
BSEFMC
23097.63
-166.57 -0.72% 23264.20 forward-arrow
BSE HC
43467.60
-125.80 -0.29% 43593.40 forward-arrow
BSE IT
42845.88
-455.10 -1.05% 43300.98 forward-arrow
MFG
1101.20
-11.54 -1.04% 1112.74 forward-arrow
ALLCAP
10846.85
-129.55 -1.18% 10976.40 forward-arrow
COMDTY
7613.42
-53.03 -0.69% 7666.45 forward-arrow
CONDIS
10476.60
-92.00 -0.87% 10568.60 forward-arrow
ENERGY
13388.69
-285.28 -2.09% 13673.97 forward-arrow
FINSER
11508.34
-171.51 -1.47% 11679.85 forward-arrow
INDSTR
15528.95
-221.81 -1.41% 15750.76 forward-arrow
LRGCAP
9726.17
-116.63 -1.18% 9842.80 forward-arrow
MIDSEL
17680.59
-240.65 -1.34% 17921.24 forward-arrow
SMLSEL
8240.04
-74.84 -0.90% 8314.88 forward-arrow
TELCOM
3160.39
-105.33 -3.23% 3265.72 forward-arrow
UTILS
6259.01
-81.95 -1.29% 6340.96 forward-arrow
BHRT22
9157.78
-179.58 -1.92% 9337.36 forward-arrow
ESG100
409.64
-4.86 -1.17% 414.50 forward-arrow
MID150
16584.48
-202.16 -1.20% 16786.64 forward-arrow
SML250
7401.43
-64.71 -0.87% 7466.14 forward-arrow
LMI250
10943.79
-134.62 -1.22% 11078.41 forward-arrow
MSL400
12668.03
-138.86 -1.08% 12806.89 forward-arrow
BSEDSI
1099.27
-13.79 -1.24% 1113.06 forward-arrow
BSEEVI
1000.10
-21.83 -2.14% 1021.93 forward-arrow
BSELVI
1899.06
-13.02 -0.68% 1912.08 forward-arrow
BSEMOI
2412.08
-32.73 -1.34% 2444.81 forward-arrow
BSEQUI
2042.51
-24.24 -1.17% 2066.75 forward-arrow
DFRGRI
1519.00
-14.56 -0.95% 1533.56 forward-arrow
LCTMCI
9338.22
-115.13 -1.22% 9453.35 forward-arrow
BSEPBI
18244.49
-244.56 -1.32% 18489.05 forward-arrow

Stay Updated with Market News and Updates

Market Buzz

Frequently Asked Questions

Is investing in the Nifty Pharma Index a good idea for beginners?

Answer Field

The Nifty Pharma Index is an index that tracks the performance of the pharmaceutical sector in India. It comprises 15 stocks that are listed on the National Stock Exchange (NSE) and have a high correlation with the global metals prices. Investing in the Nifty Pharma Index can provide exposure to the growth potential of the Indian pharmaceutical industry, which is expected to benefit from the increasing demand for healthcare products and services, both domestically and globally. However, investing in the Nifty Pharma Index also involves some risks, such as:

  • High volatility: The Nifty Pharma Index can be affected by various factors, such as regulatory changes, patent expiries, product approvals, pricing pressures, currency fluctuations, and competition. These factors can cause significant fluctuations in the index value, which can impact the returns of the investors.

  • Sector concentration: The Nifty Pharma Index is a sector-specific index, which means it does not offer diversification across different sectors or industries. Investing in a single sector can expose the investors to the sector-specific risks, which can be higher than the market risks.

  • Tracking error: The Nifty Pharma Index is a passive index, which means it does not actively manage its portfolio or adjust to the changing market conditions. The index funds or ETFs that track the Nifty Pharma Index may not be able to replicate the exact performance of the index, due to various factors, such as fees, expenses, liquidity, and rebalancing⁵. This can result in a tracking error, which is the difference between the returns of the index fund or ETF and the returns of the index.

Therefore, investing in the Nifty Pharma Index may not be a good idea for beginners, unless they have a high risk appetite, a long-term investment horizon, and a thorough understanding of the pharmaceutical sector. Beginners may be better off investing in diversified equity funds or index funds that track broader indices, such as the Nifty 50 or the Nifty 500, which can offer lower volatility, higher diversification, and lower tracking error.

 

How can I buy shares in companies listed on the Nifty Pharma Index?

Answer Field

There are two ways to buy shares in companies listed on the Nifty Pharma Index:

  • Directly: You can buy the individual shares of the companies that constitute the Nifty Pharma Index, through a stock broker or a trading platform. You will need a demat account and a trading account to do so. You will also have to pay brokerage fees, transaction charges, and taxes on your trades. You will have to monitor the performance of each company and decide when to buy or sell the shares. You will also have to bear the risk of selecting the right companies and timing the market.

  • Indirectly: You can buy an index fund or an ETF that tracks the Nifty Pharma Index, through a mutual fund house or an exchange. You will need a demat account and a trading account to do so. You will also have to pay management fees, expense ratio, and taxes on your investments. You will not have to worry about selecting the individual companies or timing the market, as the index fund or ETF will do that for you. You will also benefit from the diversification and lower tracking error of the index fund or ETF.

Can I invest in the Nifty Pharma Index through a mutual fund?

Answer Field

Yes, you can invest in the Nifty Pharma Index through a mutual fund. There are two types of mutual funds that can help you invest in the Nifty Pharma Index:

  • Index funds: These are mutual funds that invest in the same stocks and in the same proportion as the Nifty Pharma Index. They aim to replicate the performance of the index, subject to tracking error. They have low management fees, low expense ratio, and low turnover ratio. They are suitable for passive investors who want to invest in the pharmaceutical sector without taking active bets on individual companies or market movements. An example of an index fund that tracks the Nifty Pharma Index is the ICICI Prudential Nifty Pharma Index Fund.

  • Sectoral funds: These are mutual funds that invest in the pharmaceutical sector, but not necessarily in the same stocks or in the same proportion as the Nifty Pharma Index. They aim to outperform the index by taking active bets on individual companies or market movements. They have higher management fees, higher expense ratio, and higher turnover ratio. They are suitable for active investors who have a high risk appetite, a high conviction, and a deep knowledge of the pharmaceutical sector. An example of a sectoral fund that invests in the pharmaceutical sector is the Nippon India Pharma Fund.

Can I use the Nifty Pharma Index to plan for retirement?

Answer Field

The Nifty Pharma Index can be used to plan for retirement, but only as a part of a diversified portfolio that includes other asset classes, such as debt, gold, and real estate. The Nifty Pharma Index can provide long-term capital appreciation, as the pharmaceutical sector is expected to grow at a faster rate than the overall economy, due to the rising demand for healthcare products and services, both domestically and globally. However, the Nifty Pharma Index also has some drawbacks, such as:

  • High volatility: The Nifty Pharma Index can be affected by various factors, such as regulatory changes, patent expiries, product approvals, pricing pressures, currency fluctuations, and competition³. These factors can cause significant fluctuations in the index value, which can impact the returns of the investors. This can be detrimental for retirement planning, as it can erode the value of the corpus and affect the ability to meet the retirement goals.
  • Sector concentration: The Nifty Pharma Index is a sector-specific index, which means it does not offer diversification across different sectors or industries. Investing in a single sector can expose the investors to the sector-specific risks, which can be higher than the market risks. This can be risky for retirement planning, as it can increase the chances of losing money and reduce the chances of achieving the desired returns.
  • Tracking error: The Nifty Pharma Index is a passive index, which means it does not actively manage its portfolio or adjust to the changing market conditions. The index funds or ETFs that track the Nifty Pharma Index may not be able to replicate the exact performance of the index, due to various factors, such as fees, expenses, liquidity, and rebalancing. This can result in a tracking error, which is the difference between the returns of the index fund or ETF and the returns of the index. This can be harmful for retirement planning, as it can reduce the returns and increase the uncertainty of the outcome.

    Therefore, the Nifty Pharma Index can be used to plan for retirement, but only as a part of a diversified portfolio that includes other asset classes, such as debt, gold, and real estate. The Nifty Pharma Index can provide long-term capital appreciation, but it also has high volatility, sector concentration, and tracking error. The investors should have a high risk appetite, a long-term investment horizon, and a thorough understanding of the pharmaceutical sector. The investors should also monitor the performance of the index and rebalance their portfolio periodically, to maintain the desired asset allocation and risk-return profile.

What are the top-performing pharmaceutical companies in the Nifty Pharma Index?

Answer Field

According to the web search results, the top-performing pharmaceutical companies in the Nifty Pharma Index, based on the one-year returns as of December 20, 2023, are:

  • Pfizer Ltd: This company is a subsidiary of the global pharmaceutical giant Pfizer Inc. It is engaged in the manufacturing, marketing, and distribution of various pharmaceutical products, such as vaccines, antibiotics, anti-infectives, cardiovascular, and oncology drugs. It has a market capitalization of Rs. 19,376 crore and a one-year return of 26.08%.

  • Aurobindo Pharma Ltd: This company is one of the largest generic drug manufacturers in India. It is involved in the production and export of various pharmaceutical products, such as active pharmaceutical ingredients (APIs), formulations, biosimilars, and over-the-counter (OTC) products. It has a market capitalization of Rs. 60,510 crore and a one-year return of 18%.

  • Cipla Ltd: This company is one of the leading pharmaceutical companies in India. It is engaged in the development and manufacture of various pharmaceutical products, such as respiratory, urology, anti-retroviral, anti-diabetic, and anti-malarial drugs. It has a market capitalization of Rs. 99,825 crore and a one-year return of 16.67%.

  • Sun Pharmaceutical Industries Ltd: This company is the largest pharmaceutical company in India by market capitalization. It is involved in the manufacture and sale of various pharmaceutical products, such as generics, branded generics, specialty, and over-the-counter (OTC) products. It has a market capitalization of Rs. 2,98,837 crore and a one-year return of 11.67%.

  • Dr. Reddy's Laboratories Ltd: This company is one of the major pharmaceutical companies in India. It is engaged in the research and development, production, and marketing of various pharmaceutical products, such as generics, biosimilars, differentiated formulations, and new chemical entities (NCEs). It has a market capitalization of Rs. 94,044 crore and a one-year return of 10.67%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4800 Cr MTF Book

icon-with-text